These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Dvorak CC; Steinbach WJ; Brown JM; Agarwal R Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Camps IR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335 [TBL] [Abstract][Full Text] [Related]
6. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Maertens J Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370 [TBL] [Abstract][Full Text] [Related]
7. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Chamilos G; Luna M; Lewis RE; Bodey GP; Chemaly R; Tarrand JJ; Safdar A; Raad II; Kontoyiannis DP Haematologica; 2006 Jul; 91(7):986-9. PubMed ID: 16757415 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation. Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155 [TBL] [Abstract][Full Text] [Related]
15. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
16. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077 [TBL] [Abstract][Full Text] [Related]
17. Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years. Shi JM; Pei XY; Luo Y; Tan YM; Tie RX; He JS; Zheng WY; Zhang J; Cai Z; Lin MF; Huang H J Zhejiang Univ Sci B; 2015 Sep; 16(9):796-804. PubMed ID: 26365122 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic SCT in patients with a history of invasive fungal infection. Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496 [TBL] [Abstract][Full Text] [Related]